Nat Prod Rep 2021 Jul;38(7):1243-1250
Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. and Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China and Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning 530021, China and Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China and Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, China and The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen 518020, China.
Covering: Up to 2020 Artemisinin has made a significant contribution towards global malaria control since its initial discovery. Countless lives have been saved by this unique and miraculous molecule. In 2006, artemisinin-based combination therapies (ACTs) were recommended by the World Health Organization (WHO) as the first-line treatment for uncomplicated malaria infection and have since remained as the mainstays of the antimalarial treatment. Read More